Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 200

Similar articles for PubMed (Select 24860871)

1.

Erythropoiesis-driven regulation of hepcidin in human red cell disorders is better reflected through concentrations of soluble transferrin receptor rather than growth differentiation factor 15.

Fertrin KY, Lanaro C, Franco-Penteado CF, de Albuquerque DM, de Mello MR, Pallis FR, Bezerra MA, Hatzlhofer BL, Olbina G, Saad ST, da Silva Araújo A, Westerman M, Costa FF.

Am J Hematol. 2014 Apr;89(4):385-90.

PMID:
24860871
2.

Relationship between hepcidin and GDF15 in anemic patients with type 2 diabetes without overt renal impairment.

Hong JH, Choi YK, Min BK, Park KS, Seong K, Lee IK, Kim JG.

Diabetes Res Clin Pract. 2015 Jul;109(1):64-70. doi: 10.1016/j.diabres.2015.05.001. Epub 2015 May 11.

PMID:
25998917
3.

Hepcidin and iron disorders: new biology and clinical approaches.

Arezes J, Nemeth E.

Int J Lab Hematol. 2015 May;37 Suppl 1:92-8. doi: 10.1111/ijlh.12358.

PMID:
25976966
4.

Increasing serum transferrin to reduce tissue iron overload due to ineffective erythropoiesis.

Tolosano E.

Haematologica. 2015 May;100(5):565-6. doi: 10.3324/haematol.2015.124966. No abstract available.

5.

Correlation of hepcidin level with insulin resistance and endocrine glands function in major thalassemia.

Al-Hakeim HK, Al-Khakani MM, Al-Kindi MA.

Adv Clin Exp Med. 2015 Jan-Feb;24(1):69-78. doi: 10.17219/acem/38158.

6.

Elevated Hepcidin Is Part of a Complex Relation That Links Mortality with Iron Homeostasis and Anemia in Men and Women with HIV Infection.

Minchella PA, Armitage AE, Darboe B, Jallow MW, Drakesmith H, Jaye A, Prentice AM, McDermid JM.

J Nutr. 2015 Jun;145(6):1194-201. doi: 10.3945/jn.114.203158. Epub 2015 Apr 22.

7.

Hepcidin Levels Are Increased in Patients with Acute Ischemic Stroke: Preliminary Report.

Słomka A, Świtońska M, Żekanowska E.

J Stroke Cerebrovasc Dis. 2015 Jul;24(7):1570-6. doi: 10.1016/j.jstrokecerebrovasdis.2015.03.031. Epub 2015 Apr 14.

PMID:
25881778
8.

Hepcidin: Regulation of the master iron regulator.

Rishi G, Wallace DF, Subramaniam VN.

Biosci Rep. 2015 Mar 31. [Epub ahead of print]

9.

Evidence that the expression of transferrin receptor 1 on erythroid marrow cells mediates hepcidin suppression in the liver.

Keel SB, Doty R, Liu L, Nemeth E, Cherian S, Ganz T, Abkowitz JL.

Exp Hematol. 2015 Jun;43(6):469-478.e6. doi: 10.1016/j.exphem.2015.03.001. Epub 2015 Mar 14.

PMID:
25782630
10.

Järntillskott rekommenderas vid renal anemi.

Stefansson B.

Lakartidningen. 2015 Mar 10;112. pii: DDRS. Swedish.

PMID:
25756713
11.

New insights into iron regulation and erythropoiesis.

Kim A, Nemeth E.

Curr Opin Hematol. 2015 May;22(3):199-205. doi: 10.1097/MOH.0000000000000132.

PMID:
25710710
12.

Iron age: novel targets for iron overload.

Casu C, Rivella S.

Hematology Am Soc Hematol Educ Program. 2014 Dec 5;2014(1):216-21. doi: 10.1182/asheducation-2014.1.216. Epub 2014 Nov 18.

PMID:
25696858
13.

TfR2 links iron metabolism and erythropoiesis.

Pantopoulos K.

Blood. 2015 Feb 12;125(7):1055-6. doi: 10.1182/blood-2014-12-617571. No abstract available.

PMID:
25678434
14.

Regulation of cell surface transferrin receptor-2 by iron-dependent cleavage and release of a soluble form.

Pagani A, Vieillevoye M, Nai A, Rausa M, Ladli M, Lacombe C, Mayeux P, Verdier F, Camaschella C, Silvestri L.

Haematologica. 2015 Apr;100(4):458-65. doi: 10.3324/haematol.2014.118521. Epub 2015 Jan 30.

15.

The impact of maternal obesity on iron status, placental transferrin receptor expression and hepcidin expression in human pregnancy.

Garcia-Valdes L, Campoy C, Hayes H, Florido J, Rusanova I, Miranda MT, McArdle HJ.

Int J Obes (Lond). 2015 Apr;39(4):571-8. doi: 10.1038/ijo.2015.3. Epub 2015 Jan 23.

PMID:
25614087
16.

Hepcidin-25 vs. conventional clinical biomarkers in the diagnosis of functional iron deficiency.

Enko D, Wagner H, Kriegshäuser G, Kimbacher C, Stolba R, Worf E, Halwachs-Baumann G.

Eur J Haematol. 2015 Jan 18. doi: 10.1111/ejh.12523. [Epub ahead of print]

PMID:
25598480
17.

Differences in the erythropoiesis-hepcidin-iron store axis between hemoglobin H disease and β-thalassemia intermedia.

Origa R, Cazzola M, Mereu E, Danjou F, Barella S, Giagu N, Galanello R, Swinkels DW.

Haematologica. 2015 May;100(5):e169-71. doi: 10.3324/haematol.2014.115733. Epub 2015 Jan 16. No abstract available.

18.

The role of hepcidin and its related genes (BMP6, GDF-15, and HJV) in rats exposed to ischemia and reperfusion.

Dokuyucu R, Demir T, Yumrutaş Onder, Erbağci AB, Orkmez M, Bahar AY, Bayraktar R, Bozgeyik I, Kaplan DS, Cengiz B, Bağci BC.

Turk J Med Sci. 2014;44(4):576-81.

PMID:
25551924
19.

Microcytic anemia in a pregnant woman: beyond iron deficiency.

Rollón N, Fernández-Jiménez MC, Moreno-Carralero MI, Murga-Fernández MJ, Morán-Jiménez MJ.

Int J Hematol. 2015 May;101(5):514-9. doi: 10.1007/s12185-014-1723-7. Epub 2014 Dec 30.

PMID:
25547425
20.

New Insights on Iron Study in Myelodysplasia.

El Husseiny NM, Mehaney DA, El Kader Morad MA.

Turk J Haematol. 2014 Dec 5;31(4):394-398. doi: 10.4274/tjh.2012.0154.

PMID:
25541657
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk